Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA411625
Max Phase: Preclinical
Molecular Formula: C57H98N16O15
Molecular Weight: 1247.51
Molecule Type: Small molecule
Associated Items:
ID: ALA411625
Max Phase: Preclinical
Molecular Formula: C57H98N16O15
Molecular Weight: 1247.51
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCNC(=O)CO)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O
Standard InChI: InChI=1S/C57H98N16O15/c1-31(2)12-10-11-15-44(77)64-36(16-22-58)52(83)73-47(34(6)76)57(88)69-39(19-25-61)49(80)67-40-21-27-63-56(87)46(33(5)75)72-53(84)41(20-26-62-45(78)30-74)68-48(79)37(17-23-59)66-54(85)42(28-32(3)4)70-55(86)43(29-35-13-8-7-9-14-35)71-50(81)38(18-24-60)65-51(40)82/h7-9,13-14,31-34,36-43,46-47,74-76H,10-12,15-30,58-61H2,1-6H3,(H,62,78)(H,63,87)(H,64,77)(H,65,82)(H,66,85)(H,67,80)(H,68,79)(H,69,88)(H,70,86)(H,71,81)(H,72,84)(H,73,83)/t33-,34-,36+,37+,38+,39+,40+,41+,42+,43-,46+,47+/m1/s1
Standard InChI Key: RNQCKCYGEQEOCW-BMDFICIHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1247.51 | Molecular Weight (Monoisotopic): 1246.7398 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Weinstein J, Afonso A, Moss E, Miller GH.. (1998) Selective chemical modifications of polymyxin B., 8 (23): [PMID:9873740] [10.1016/s0960-894x(98)00612-x] |
Source(1):